Dbv Technologies
Clinical trials sponsored by Dbv Technologies, explained in plain language.
-
Peanut patch for toddlers: could a sticker ease allergy fears?
Disease control OngoingThis study is testing a skin patch called Viaskin that delivers a tiny amount of peanut protein to help 1-3 year olds with peanut allergy. The goal is to see if the patch is safe over 6 months. About 480 children will wear the patch or a placebo daily. This is a phase 3 trial, me…
Phase: PHASE3 • Sponsor: DBV Technologies • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Peanut patch could let allergic kids tolerate small amounts of peanut
Disease control OngoingThis study tests a daily skin patch called DBV712 (Viaskin Peanut) in 600 children aged 4-7 with peanut allergy. The patch delivers a tiny amount of peanut protein to train the immune system to be less sensitive. After 12 months, researchers check if children can safely eat more …
Phase: PHASE3 • Sponsor: DBV Technologies • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC